Rajavtihi Neuronal Adult Stem Cells Project
NCT00927108 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL
Last updated 2020-10-19
Summary
To study the success of Oligodendrocyte progenitor cell culture project in Rajavithi Hospital to identify an unlimited clone human neuronal progenitor stem cells from the human brain in the Biomolecular Research Center. This study aims to produce the reproductive clone of neuronal development protocols and advance projects. Neuronal cells such as pyramidal cells, oligodendrocyte, and dopaminergic neuron differentiation protocol/projects for treatment of Alzheimer's disease, Multiple sclerosis, and Parkinson's disease respectively in next phase of clinical trials.
Conditions
Interventions
- OTHER
-
Progenitor Stem Cell Culture
Sponsors & Collaborators
-
Rajavithi Biomolecular Research Center
collaborator OTHER -
Department of Medical Services Ministry of Public Health of Thailand
lead OTHER_GOV
Principal Investigators
-
Subsai Kongsaengdao, M.D. · Department of Medical Services Ministry of Public Health of Thailand
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 20 Years
- Max Age
- 120 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2009-07-31
- Primary Completion
- 2011-12-31
- Completion
- 2011-12-31
Countries
- Thailand
Study Locations
More Related Trials
-
Bone Marrow Mononuclear Cells vs Mesenchymal Stem Cells in Diabetic Patients With Chronic Limb Ischemia
NCT05631444 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Autologous Activated Adipose-derived Stem Cells (RB-ADSC) Injected Directly Into the Brain for Mild to Moderate Alzheimer's Disease
NCT05667649 ·Status: RECRUITING ·Phase: PHASE1
-
Safety and Efficacy of Autologous Bone Marrow Mononuclear Cells in Patients With Severe Critical Limb Ischemia
NCT01472289 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Efficacy of Autologous Stem Cell Therapy in Chronic Stroke
NCT02065778 ·Status: WITHDRAWN ·Phase: PHASE1
-
Autologous Bone Marrow-Derived Stem Cell Therapy for Motor Neuron Disease
NCT03067857 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Clinical Trial to Study the Efficacy and Safety of Stempeucel® in Patients With CLI Due to Buergers Disease
NCT03056742 ·Status: WITHDRAWN ·Phase: PHASE2
-
Safety and Effects of Autologous Adipose-Derived Stromal Cells in Patients With Diffuse Lesions in the Brain
NCT01453777 ·Status: WITHDRAWN ·Phase: NA
-
Autologous Bone Marrow Derived Mesenchymal Stromal Cells Transplantation(BM-MSC) for Kienbock's Disease
NCT02646007 ·Status: UNKNOWN ·Phase: PHASE1
-
Cell Therapy With Mesenchymal Stem Cell in Ischemic Limb Disease
NCT02336646 ·Status: COMPLETED ·Phase: PHASE1
-
Cell Therapy With Bone Marrow Mononuclear Cells in Critical Leg Ischemia (CLI)
NCT00377897 ·Status: UNKNOWN ·Phase: PHASE1
-
Autologous Transplantation of Bone Marrow Mononuclear Cell (BM-MNC) With and Without Granulocyte-Colony Stimulation Factor (G-CSF) for Treatment of Chronic Lower Limb Ischemic Patients
NCT00677404 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
MSC Therapy in Liver Transplantation
NCT02260375 ·Status: RECRUITING ·Phase: PHASE1
-
Manufacturing of Allogeneic Adipose Tissue-derived Mesenchymal Stromal Cells for Treatment of Severe Systemic Sclerosis
NCT05947682 ·Status: UNKNOWN ·Phase: NA
-
A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease
NCT01484574 ·Status: COMPLETED ·Phase: PHASE2
-
Regenerative Effects of Birth Material Derived Extracellular Vesicles
NCT06866184 ·Status: NOT_YET_RECRUITING
-
Cellular & Biocellular Regenerative Therapy in Musculoskeletal Pain, Dysfunction,Degenerative or Inflammatory Disease
NCT03090672 ·Status: UNKNOWN ·Phase: NA
-
Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Chronic Kidney Disease
NCT05362786 ·Status: COMPLETED ·Phase: PHASE1
-
Autologous Bone Marrow Stromal Cell and Endothelial Progenitor Cell Transplantation in Ischemic Stroke
NCT01468064 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Efficacy Study of Autologous BM-MNC Processed by Two Methods for Treating Patients With Chronic Limb Ischemia
NCT01446055 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Autologous Bone Marrow Mononuclear Cell Transplantation for Stroke Patients
NCT01028794 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Autologous Bone Marrow Mesenchymal Stem Cell Therapy for Ischemic Stroke
NCT06997939 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Autologous Endothelial Progenitor Cells (EPCs) From Peripheral Blood in the Treatment of Critical Limb Ischemia
NCT01595776 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Stem Cell Ophthalmology Treatment Study
NCT01920867 ·Status: UNKNOWN ·Phase: NA
-
Intravenous Autologous Bone Marrow-derived Stem Cells Therapy for Patients With Acute Ischemic Stroke
NCT01501773 ·Status: COMPLETED ·Phase: PHASE2
-
MSC and Kidney Transplant Tolerance (Phase A)
NCT02565459 ·Status: UNKNOWN ·Phase: PHASE1